The company has axed 80% of its staff and is considering a wind-down after the out-licencing deal of its lead antifungal was ...

Solventum, the healthcare company spun off from 3M earlier this year, has retained bankers to explore a sale of its ...

Xeris' Q2 net revenue grew 86% year-over-year to hit $13.3M, with the average number of patients on Recorlev up 124%. With an estimated 2-3M people suffering from Cushing's syndrome around the ...

In a report released today, Edward Tenthoff from Piper Sandler reiterated a Buy rating on Sutro Biopharma (STRO – Research Report), with ...

After hours: November 4 at 5:39 PM EST Loading Chart for LSB ...

After hours: October 25 at 4:02 PM EDT ...

Cue Biopharma (NASDAQ:CUE), Inc., a pharmaceutical company, announced today an increase in its authorized capital. The decision, made during a Special Meeting of Stockholders on Monday ...

*For more details about COVID-19 therapeutics and vaccines, diagnostic products and clinical trial delays, go to BioWorld Snapshots.

Sunshine Biopharma, Inc., a Colorado-based pharmaceutical company, announced a significant change to its capital structure. Effective as of last Wednesday, the ...

After hours: 5 November at 6:38 pm GMT-5 ...